CAS 143443-90-7|Ifetroban
Introduction:Basic information about CAS 143443-90-7|Ifetroban, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Ifetroban | ||
|---|---|---|---|
| CAS Number | 143443-90-7 | Molecular Weight | 440.53200 |
| Density | 1.206g/cm3 | Boiling Point | 663.6ºC at 760mmHg |
| Molecular Formula | C25H32N2O5 | Melting Point | / |
| MSDS | / | Flash Point | 355.1ºC |
Names
| Name | Ifetroban |
|---|
Ifetroban BiologicalActivity
| Description | Ifetroban is a long-acting thromboxane A2 receptor antagonist, with antiplatelet activity[1]. |
|---|---|
| Related Catalog | Research Areas >>Cardiovascular DiseaseResearch Areas >>EndocrinologySignaling Pathways >>GPCR/G Protein >>Prostaglandin Receptor |
| Target | Thromboxane A2 receptor[1] |
| In Vitro | Ifetroban is a long-acting thromboxane/prostaglandin endoperoxide receptor antagonist, with antiplatelet activity[1]. |
| In Vivo | Ifetroban (20, 40 mg/kg/day, i.p.) shows no effect on the blood pressure in stroke-prone spontaneously hypertensive rats[1]. Ifetroban (BMS 180,291; 1 and 3 mg/kg, p.o.) inhibits aggregation and antagonizes TP-receptor in monekys. Ifetroban (3 mg/kg, i.v.) causes only marginal and transient hemodynamic effects in anesthetized African green monkeys[2]. |
| References | [1]. Johnson RA, et al. Effect of ifetroban, a thromboxane A2 receptor antagonist, in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1996 Feb;18(2):171-88. [2]. Schumacher WA, et al. Antiplatelet activity of the long-acting thromboxane receptor antagonist BMS 180,291 in monkeys. Prostaglandins. 1992 Nov;44(5):389-97. |
Chemical & Physical Properties
| Density | 1.206g/cm3 |
|---|---|
| Boiling Point | 663.6ºC at 760mmHg |
| Molecular Formula | C25H32N2O5 |
| Molecular Weight | 440.53200 |
| Flash Point | 355.1ºC |
| Exact Mass | 440.23100 |
| PSA | 101.66000 |
| LogP | 4.50640 |
| Index of Refraction | 1.566 |
| InChIKey | BBPRUNPUJIUXSE-DXKRWKNPSA-N |
| SMILES | CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 |
